ArticleClinical kidney journal2021

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia.

Bojun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.